Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dr Reddys Laboratories (RDY) Short term Debt (2018 - 2025)

Historic Short term Debt for Dr Reddys Laboratories (RDY) over the last 14 years, with Q4 2025 value amounting to $564.7 million.

  • Dr Reddys Laboratories' Short term Debt changed N/A to $564.7 million in Q4 2025 from the same period last year, while for Dec 2025 it was $564.7 million, marking a year-over-year change of. This contributed to the annual value of $445.0 million for FY2025, which is 19084.97% up from last year.
  • As of Q4 2025, Dr Reddys Laboratories' Short term Debt stood at $564.7 million.
  • Dr Reddys Laboratories' 5-year Short term Debt high stood at $564.7 million for Q4 2025, and its period low was $232.15 during Q2 2022.
  • For the 5-year period, Dr Reddys Laboratories' Short term Debt averaged around $265.9 million, with its median value being $300.1 million (2021).
  • Its Short term Debt has fluctuated over the past 5 years, first plummeted by 9999.99% in 2022, then soared by 3391203165.11% in 2023.
  • Over the past 5 years, Dr Reddys Laboratories' Short term Debt (Quarter) stood at $284.7 million in 2021, then crashed by 50.94% to $139.7 million in 2022, then crashed by 49.36% to $70.7 million in 2023, then skyrocketed by 574.8% to $477.3 million in 2024, then grew by 18.31% to $564.7 million in 2025.
  • Its Short term Debt was $564.7 million in Q4 2025, compared to $471.7 million in Q3 2025 and $439.3 million in Q1 2025.